$0.3340
In chiusura: Aug 25 EDT
$0.3338
-0.00020-0.06%
Pre-mercato: 5:04 AM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su VYNE Therapeutics Inc (NASDAQ:VYNE) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 333.48K a 2.09M. Questo rappresenta il 12.67% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in VYNE Therapeutics Corp (XNAS:VYNE) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 4.27M azioni scambiate al giorno, ci vorrebbero 1 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
2.09M
Vendite allo scoperto %
12.7%
Giorni di copertura
1
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
VYNE | VYNE Therapeutics Inc. Common | 07/31/2025 | 08/11/2025 | 12.67% | 16,496,225 | 2,090,114 | 4,270,097 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 07/15/2025 | 07/24/2025 | 2.02% | 16,496,225 | 333,476 | 943,944 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 06/30/2025 | 07/10/2025 | 4.97% | 16,496,225 | 819,146 | 1,692,552 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 06/13/2025 | 06/25/2025 | 2.09% | 16,496,225 | 344,165 | 334,171 | 1.03 | |
VYNE | VYNE Therapeutics Inc. Common | 05/30/2025 | 06/10/2025 | 2.03% | 16,496,225 | 334,569 | 359,914 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 05/15/2025 | 05/27/2025 | 1.38% | 16,496,225 | 227,933 | 150,260 | 1.52 | |
VYNE | VYNE Therapeutics Inc. Common | 04/30/2025 | 05/09/2025 | 1.49% | 14,582,766 | 217,471 | 298,634 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 04/15/2025 | 04/25/2025 | 1.31% | 14,582,766 | 191,069 | 130,375 | 1.47 | |
VYNE | VYNE Therapeutics Inc. Common | 03/31/2025 | 04/09/2025 | 0.93% | 14,582,766 | 135,679 | 286,661 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 03/14/2025 | 03/25/2025 | 1.03% | 14,582,766 | 150,482 | 76,889 | 1.96 | |
VYNE | VYNE Therapeutics Inc. Common | 02/28/2025 | 03/11/2025 | 0.85% | 14,582,766 | 123,785 | 59,873 | 2.07 | |
VYNE | VYNE Therapeutics Inc. Common | 02/14/2025 | 02/26/2025 | 0.96% | 14,582,766 | 139,805 | 80,482 | 1.74 | |
VYNE | VYNE Therapeutics Inc. Common | 01/31/2025 | 02/11/2025 | 0.84% | 14,582,766 | 123,202 | 96,576 | 1.28 | |
VYNE | VYNE Therapeutics Inc. Common | 01/15/2025 | 01/27/2025 | 0.77% | 14,582,766 | 112,326 | 179,483 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 12/31/2024 | 01/10/2025 | 0.42% | 14,582,766 | 61,351 | 125,734 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 12/13/2024 | 12/24/2024 | 0.43% | 14,582,766 | 62,376 | 81,435 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 11/29/2024 | 12/10/2024 | 0.44% | 14,582,766 | 64,265 | 65,149 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 11/15/2024 | 11/26/2024 | 0.70% | 14,582,766 | 102,169 | 138,616 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 10/31/2024 | 11/11/2024 | 0.56% | 14,649,212 | 82,561 | 135,525 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 10/15/2024 | 10/24/2024 | 0.34% | 14,649,212 | 49,968 | 47,868 | 1.04 | |
VYNE | VYNE Therapeutics Inc. Common | 09/30/2024 | 10/09/2024 | 0.40% | 14,649,212 | 58,194 | 32,507 | 1.79 | |
VYNE | VYNE Therapeutics Inc. Common | 09/13/2024 | 09/24/2024 | 0.23% | 14,649,212 | 33,138 | 43,922 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 08/30/2024 | 09/11/2024 | 0.32% | 14,649,212 | 46,500 | 19,094 | 2.44 | |
VYNE | VYNE Therapeutics Inc. Common | 07/31/2024 | 08/09/2024 | 0.46% | 14,428,062 | 66,752 | 42,628 | 1.57 | |
VYNE | VYNE Therapeutics Inc. Common | 07/15/2024 | 07/24/2024 | 0.43% | 14,428,062 | 61,768 | 42,852 | 1.44 | |
VYNE | VYNE Therapeutics Inc. Common | 06/28/2024 | 07/10/2024 | 0.39% | 14,428,062 | 55,857 | 120,055 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 06/14/2024 | 06/26/2024 | 0.43% | 14,428,062 | 62,680 | 36,668 | 1.71 | |
VYNE | VYNE Therapeutics Inc. Common | 05/31/2024 | 06/11/2024 | 0.36% | 14,428,062 | 51,275 | 28,099 | 1.82 | |
VYNE | VYNE Therapeutics Inc. Common | 05/15/2024 | 05/24/2024 | 0.40% | 14,428,062 | 57,356 | 51,403 | 1.12 | |
VYNE | VYNE Therapeutics Inc. Common | 04/30/2024 | 05/09/2024 | 0.57% | 14,428,062 | 81,960 | 62,280 | 1.32 | |
VYNE | VYNE Therapeutics Inc. Common | 04/15/2024 | 04/24/2024 | 0.69% | 13,998,703 | 96,825 | 110,648 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 03/28/2024 | 04/09/2024 | 0.61% | 13,998,703 | 85,622 | 231,077 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 03/15/2024 | 03/26/2024 | 0.09% | 13,998,703 | 12,441 | 73,285 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 02/29/2024 | 03/11/2024 | 0.24% | 13,998,703 | 33,856 | 76,042 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 01/31/2024 | 02/09/2024 | 0.38% | 13,857,139 | 52,494 | 68,751 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 01/12/2024 | 01/24/2024 | 0.64% | 13,857,139 | 88,015 | 265,784 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 12/29/2023 | 01/10/2024 | 0.63% | 13,857,139 | 87,985 | 57,218 | 1.54 | |
VYNE | VYNE Therapeutics Inc. Common | 12/15/2023 | 12/27/2023 | 0.05% | 13,857,139 | 7,018 | 97,804 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 11/30/2023 | 12/11/2023 | 0.90% | 13,857,139 | 124,783 | 37,012 | 3.37 | |
VYNE | VYNE Therapeutics Inc. Common | 11/15/2023 | 11/27/2023 | 1.06% | 13,857,139 | 146,819 | 106,362 | 1.38 | |
VYNE | VYNE Therapeutics Inc. Common | 10/31/2023 | 11/09/2023 | 1.80% | 3,243,903 | 58,510 | 1,712,882 | 1 | |
VYNE | VYNE Therapeutics Inc. Common | 10/13/2023 | 10/24/2023 | 1.62% | 3,243,903 | 52,413 | 15,117 | 3.47 | |
VYNE | VYNE Therapeutics Inc. Common | 09/29/2023 | 10/10/2023 | 1.75% | 3,243,903 | 56,718 | 9,648 | 5.88 | |
VYNE | VYNE Therapeutics Inc. Common | 09/15/2023 | 09/26/2023 | 1.90% | 3,243,903 | 61,715 | 6,867 | 8.99 | |
VYNE | VYNE Therapeutics Inc. Common | 08/31/2023 | 09/12/2023 | 1.90% | 3,243,903 | 61,766 | 11,540 | 5.35 |
In cerca di azioni più vendute allo scoperto?